Novel estrogen receptor ligands and methods iii
CA 2430769 A1 · Owner: Liu, Ye · Inventors: Liu, Ye; Gillner, Mikael; Mosley, Ralph Troy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds of formula (I) and derivatives thereof, in which the variables are as defined in the claims their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including bone loss, bone fractures osteoporosis, cartilage , degeneration endometriosis, uterine fibroid disease hot flashes, increased , levels of LDL cholesterol cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders restinosis, gynecomastia, autoimmune disease …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 28, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 28, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.